3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
2
Phase NA
1
Status
Terminated
1
Completed
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Gastrointestinal
2
Sarcoma
1
Head & Neck
1
Conditions
Visceral Pain
1
Pancreatic Neoplasms
1
Liver Neoplasms
1
Interventions
Oxaliplatin
21
Capecitabine
19
Fluorouracil
16
Bevacizumab
16
Esomeprazole
11
Sorafenib
10
Irinotecan
9
Leucovorin
8
Radiofrequency Ablation
7
Propofol
7
Bismuth
7
Morphine
6
Gemcitabine
6
Folfox protocol
6
Amoxicillin
6
lenvatinib
5
gadolinium ethoxybenzyl DTPA
5
Tetracycline
5
Sevoflurane
5
S 1 (combination)
5
Drug Therapy
5
Control Groups
5
Cisplatin
5
sodium glycididazole
4
fish oil triglycerides
4
ferric carboxymaltose
4
Sodium Chloride
4
Ropivacaine
4
Ribavirin
4
Hepatectomy
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 4
×
Pregabalin
×
Gastrointestinal
×
Clear all
NCT03151213
2026-03-13
pregabalin
Tanta University
Phase 4
Completed
70 enrolled
NCT01768988
2017-10-06
PANPAIN/1
Parc de Salut Mar
Phase 4
Terminated
20 enrolled